SearchDictionaryMobileLogin

Adult Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)

5786  relevant articles (322 outcomes, 638 trials/studies) found for this Disease

Description: A syndrome of life-threatening progressive pulmonary insufficiency in the absence of known pulmonary disease, usually following a systemic insult such as SURGERY or major TRAUMA.

Also Known As:
Acute Respiratory Distress Syndrome; Acute Lung Injury; Shock Lung; Respiratory Distress Syndrome, Adult; ARDSs, Human; Acute Lung Injuries; Atelectases, Congestive; Congestive Atelectases; Congestive Atelectasis; Human ARDS; Injuries, Acute Lung; Injury, Acute Lung; Lung Injuries, Acute; Lung, Shock; ARDS, Human; Atelectasis, Congestive; Lung Injury, Acute; Respiratory Distress Syndrome, Acute

Relationship Network

Disease Context: Research Results

Related Diseases

1. Adult Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
2. Sepsis (Septicemia)
3. Pulmonary Hypertension (Ayerza Syndrome)
4. Pulmonary Edema
5. Syndrome

Experts

1. Matthay, Michael A: 33 articles (09/2008 - 03/2002)
2. Ware, Lorraine B: 23 articles (09/2008 - 03/2002)
3. Thompson, B Taylor: 16 articles (09/2008 - 04/2003)
4. Traber, Daniel L: 15 articles (08/2008 - 09/2002)
5. Ishizaka, Akitoshi: 14 articles (06/2008 - 11/2002)
6. Enkhbaatar, Perenlei: 13 articles (02/2008 - 03/2003)
7. Traber, Lillian D: 13 articles (02/2008 - 09/2002)
8. Cox, Robert A: 12 articles (02/2008 - 09/2002)
9. Chen, Hsing I: 11 articles (07/2008 - 05/2003)
10. Garcia, Joe G N: 10 articles (10/2008 - 11/2004)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Adult Respiratory Distress Syndrome:
1. Nitric Oxide (Nitrogen Monoxide)FDA Link
2. Oleic Acid (Oleate)IBA
3. OxygenIBA
4. Alprostadil (Muse)FDA LinkGeneric
5. CytokinesIBA
6. MethylprednisoloneFDA LinkGeneric
7. Adrenal Cortex Hormones (Corticosteroids)IBA
8. Acetylcysteine (Siran)FDA LinkGeneric
9. Complement System Proteins (Complement)IBA
10. Dexamethasone (Maxidex)FDA LinkGeneric

Therapies and Procedures

1. Positive-Pressure Respiration (PEEP)
05/01/2002 - "OBJECTIVE: To compare the ease and efficacy of two commonly used methods for choosing optimal positive end-expiratory pressure (PEEP) in patients with acute respiratory distress syndrome: a static pressure-volume curve to determine the lower inflection point (P(flex)) and the "best PEEP" (PEEP(best)) as determined by the maximal compliance curve"
04/01/2003 - "A recently published randomized, controlled trial in acute respiratory distress syndrome patients (n = 148) comparing HFOV with a pressure-control ventilation strategy (Pao(2)/Fio(2) ratio of <or=200 mm Hg on positive end-expiratory pressure of >10 cm H(2)O) demonstrated early (<16 hrs) improvement in Pao(2)/Fio(2) (p =.008) in the HFOV group but no significant difference in oxygenation index between the two groups during the initial 72 hrs of treatment"
10/01/1996 - "We hypothesized that using a high-frequency pressure-control mode of ventilation with high PEEP in children with severe acute respiratory distress syndrome (ARDS) would be associated with improved survival"
08/01/1986 - "Early experiments demonstrated a diminution of cardiac output with the application of positive end-expiratory pressure, and it was not favored as a therapeutic modality until the 1960s, when it was found to be effective in the treatment of adult respiratory distress syndrome"
09/01/1979 - "Early application of an adjusted level of positive end-expiratory pressure using CPAP in patients with adequate levels of fluid is an effective and safe method of treating selected groups of patients in the early stages of the adult respiratory distress syndrome."
Order ALL the reference details at left...
2. Liquid Ventilation
3. Artificial Respiration (Mechanical Ventilation)
4. Mechanical Ventilators (Ventilator)
5. Resuscitation

Best Treatments:
Research Summary Report
on Adult Respiratory Distress Syndrome

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 322 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>